| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/29/2026 | ±2.8% | +6.0% | under-priced |
| 02/06/2026 | ±2.9% | +8.5% | under-priced |
| 10/30/2025 | ±1.8% | +1.2% | over-priced |
| 07/31/2025 | ±2.3% | +1.1% | over-priced |
| 05/01/2025 | ±2.4% | -0.1% | over-priced |
| 02/12/2025 | ±2.6% | -4.3% | under-priced |
| 10/30/2024 | ±2.3% | -1.3% | over-priced |
| 08/01/2024 | ±4.5% | -1.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.15 | $2.5B | $320M |
| Q4 FY2025 | — | $2.3B | $-49M |
| Q3 FY2025 | $3.17 | $2.5B | $467M |
| Q2 FY2025 | $4.33 | $2.6B | $635M |
BIIB (BIIB) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 3.0% on average — the market has been roughly fair on BIIB's earnings risk. Fundamentals into the print: EPS up 31.1% year-over-year, revenue up 1.9%. QuantLogix's live 5-factor engine currently reads BIIB as a buy at 91/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →